RTW Biotech Opportunities (LON:RTW – Get Free Report)’s share price rose 0.5% during mid-day trading on Tuesday . The company traded as high as GBX 2.21 and last traded at GBX 2.20. Approximately 290,412 shares traded hands during mid-day trading, a decline of 68% from the average daily volume of 903,917 shares. The stock had previously closed at GBX 2.19.
RTW Biotech Opportunities Stock Performance
The stock has a market cap of £7.00 million, a price-to-earnings ratio of 0.03 and a beta of 0.78. The company has a 50 day moving average of GBX 2.13 and a 200-day moving average of GBX 2.10.
RTW Biotech Opportunities Company Profile
RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives. RTW Bio is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.
See Also
- Five stocks we like better than RTW Biotech Opportunities
- Coke’s $10B India IPO Plan Pops the Top on Hidden Value
- FedEx Unboxes Billions in Post-Spinoff Value
- Marvell’s AI Moment Raises a Bigger Question for Amazon and ServiceNow
- Palo Alto Networks Accelerates Growth 31% on AI Demand
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
